Filing Details
- Accession Number:
- 0001179110-20-009704
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-11 20:34:42
- Reporting Period:
- 2020-09-09
- Accepted Time:
- 2020-09-11 20:34:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1697362 | Burkes Michael Brophy | C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-09 | 3,021 | $0.00 | 57,466 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-10 | 1,236 | $60.77 | 56,230 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2020-09-09 | 3,021 | $0.00 | 3,021 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
18,125 | No | 4 | M | Direct |
Footnotes
- Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 9, 2019.
- Each RSU represents a contingent right to receive one share of the common stock of the issuer.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs. The Reporting Person is subject to a Lock-Up Letter Agreement. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.76 to $61.15 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These reported shares are subject to restrictions in a Lock-Up Letter Agreement that expire on November 10, 2020.
- The RSUs vest over four years. 25% of the RSUs vest on March 9, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter.